Physician profile
Scott K Berman
NPI 1659302271
$697.07
in general payments reported to CMS, 2019-2025
14 companies · $70.96 in 2025
The $70.96 reported for 2025 was less than what a typical Thoracic Surgery (Cardiothoracic Vascular Surgery) provider received nationally (typical 2025 total: $796).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $20.48 · 2020: $18.21 · 2021: $149 · 2022: $280 · 2023: $13.12 · 2024: $145 · 2025: $70.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $229.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $180.00 | 2021-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Cook Medical LLC | $96.94 | 2020-2025 | Zenith Spiral-Z, Advance |
| Atricure, INC. | $62.18 | 2022 | |
| Imbed Biosciences INC. | $52.01 | 2022 | |
| Philips North America LLC | $45.66 | 2022 | |
| Medtronic, INC. | $44.90 | 2021 | |
| Tactile Systems Technology INC | $43.43 | 2022-2024 | Flexitouch Plus, Entre Plus |
| Acera Surgical, INC. | $42.80 | 2022 | |
| Angiodynamics, INC. | $24.84 | 2021 | |
| Endologix LLC | $24.28 | 2021 | |
| Resmed Corp | $24.23 | 2022 | |
| Boston Scientific Corporation | $21.52 | 2022 | |
| Medtronic Vascular, INC. | $20.48 | 2019 | |
| Reprise Biomedical, INC. | $13.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Berman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.